The efficacy of sacubitril/valsartan in patients receiving peritoneal dialysis with diabetes and heart failure with preserved ejection fraction
Lists
Only you see this
Abstract
The findings suggest that sacubitril/valsartan can safely and effectively improve RRF and cardiac function in patients with diabetes combined with HFpEF receiving PD, but it has little effect on PD adequacy.
BibTeX
@inproceedings{bian2024efficacy,
author = {Xueyan Bian and Siwei Ma and Qin Su and Qiang Yu and Jiancheng Huang and Sizeng Bao and Ying Ji},
title = {{The efficacy of sacubitril/valsartan in patients receiving peritoneal dialysis with diabetes and heart failure with preserved ejection fraction}},
booktitle = {Clinical},
year = {2024},
doi = {10.5414/cn111320},
}Loading related content...